Labcorp Holdings Inc (LH)

Labcorp Announces Nationwide Availability of ColoSense®, the First FDA-Approved RNA-Based At-Home Colorectal Cancer Screening Test

Labcorp Announces Nationwide Availability of ColoSense®, the First FDA-Approved RNA-Based At-Home Colorectal...

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer

Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer PR Newswire...

Labcorp Launches Expanded DPYD Test to Identify Cancer Patients at Risk for Severe Chemotherapy Side Effects

Labcorp Launches Expanded DPYD Test to Identify Cancer Patients at Risk for Severe Chemotherapy Side Effects...

Form 8-K - Current report

Labcorp to Present at the Jefferies Global Healthcare Conference

Labcorp to Present at the Jefferies Global Healthcare Conference PR Newswire BURLINGTON, N.C., May 27...

Form 8-K - Current report

Form SD - Specialized disclosure report

Labcorp Launches MyLabcorp™, a New AI-Powered Mobile App Designed to Help Consumers Understand Lab Results and Track Health Trends Over Time

Labcorp Launches MyLabcorp™, a New AI-Powered Mobile App Designed to Help Consumers Understand Lab Results...

Labcorp and Epic Expand Collaboration to Advance Diagnostic Integration across Hospitals and Health Systems

Labcorp and Epic Expand Collaboration to Advance Diagnostic Integration across Hospitals and Health Systems...

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report